Multiple activating and repressive cis-promoter regions regulate TNFSF15 expression in human primary mononuclear cells

Cytokine

Volumn 63, Issue 1, 2013, Pages 36-42

  Gonsky, Rivkah ^a   Deem, Richard L ^a   Targan, Stephan R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Gene promoter; Gene regulation; Inflammation; TL1A; TNFSF15

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CIS TRANS ISOMERISM; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IONOMYCIN; LEUKOCYTES, MONONUCLEAR; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84878916447     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.04.004     Document Type: Article

References (32)

1. Migone T.S., Zhang J., Luo X., Zhuang L., Chen C., Hu B., et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002, 16:479-492.
2. Prehn J.L., Thomas L.S., Landers C.J., Yu Q.T., Michelsen K.S., Targan S.R. The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. J Immunol 2007, 178:4033-4038.
3. Shih D.Q., Kwan L.Y., Chavez V., Cohavy O., Gonsky R., Chang E.Y., et al. Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur J Immunol 2009, 39:3239-3250.
4. Papadakis K.A., Zhu D., Prehn J.L., Landers C., Avanesyan A., Lafkas G., et al. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes. J Immunol 2005, 174:4985-4990.
5. Papadakis K.A., Prehn J.L., Landers C., Han Q., Luo X., Cha S.C., et al. TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells. J Immunol 2004, 172:7002-7007.
6. Heidemann S.C., Chavez V., Landers C.J., Kucharzik T., Prehn J.L., Targan S.R. TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets. J Clin Immunol 2010, 30:531-538.
7. Jones G.W., Stumhofer J.S., Foster T., Twohig J.P., Hertzog P., Topley N., et al. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J 2011, 25:409-419.
8. Kamada N., Hisamatsu T., Honda H., Kobayashi T., Chinen H., Takayama T., et al. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. Inflamm Bowel Dis 2010, 16:568-575.
9. Pappu B.P., Borodovsky A., Zheng T.S., Yang X., Wu P., Dong X., et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J Exp Med 2008, 205:1049-1062.
10. Takedatsu H., Michelsen K.S., Wei B., Landers C.J., Thomas L.S., Dhall D., et al. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 2008, 135:552-567.
11. Fang L., Adkins B., Deyev V., Podack E.R. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J Exp Med 2008, 205:1037-1048.
12. Al-Lamki R.S., Wang J., Tolkovsky A.M., Bradley J.A., Griffin J.L., Thiru S., et al. TL1A both promotes and protects from renal inflammation and injury. J Am Soc Nephrol 2008, 19:953-960.
13. Zhang J., Wang X., Fahmi H., Wojcik S., Fikes J., Yu Y., et al. Role of TL1A in the pathogenesis of rheumatoid arthritis. J Immunol 2009, 183:5350-5357.
14. Zucchelli M., Camilleri M., Andreasson A.N., Bresso F., Dlugosz A., Halfvarson J., et al. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut 2011, 60:1671-1677.
15. Bamias G., Martin C., Marini M., Hoang S., Mishina M., Ross W.G., et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol 2003, 171:4868-4874.
16. Bamias G., Kaltsa G., Siakavellas S.I., Papaxoinis K., Zampeli E., Michopoulos S., et al. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis. Clin Immunol 2010, 137:242-249.
17. Prehn J.L., Mehdizadeh S., Landers C.J., Luo X., Cha S.C., Wei P., et al. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin Immunol 2004, 112:66-77.
18. Meylan F., Song Y.J., Fuss I., Villarreal S., Kahle E., Malm I.J., et al. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol 2011, 4:172-185.
19. Shih D.Q., Michelsen K.S., Barrett R.J., Biener-Ramanujan E., Gonsky R., Zhang X., et al. Insights into TL1A and IBD pathogenesis. Adv Exp Med Biol 2011, 691:279-288.
20. Michelsen K.S., Thomas L.S., Taylor K.D., Yu Q.T., Mei L., Landers C.J., et al. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS ONE 2009, 4:e4719.
21. Haritunians T., Taylor K.D., Targan S.R., Dubinsky M., Ippoliti A., Kwon S., et al. Genetic predictors of medically refractory ulcerative colitis. Inflamm Bowel Dis 2010, 16:1830-1840.
22. Barrett R., Zhang X., Koon H.W., Vu M., Chang J.Y., Yeager N., et al. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis. Am J Pathol 2012, 180:636-649.
23. Hirano A., Yamazaki K., Umeno J., Ashikawa K., Aoki M., Matsumoto T., et al. Association study of 71 European crohn's disease susceptibility loci in a Japanese population. Inflamm Bowel Dis 2013, 19:526-533.
24. Shih D.Q., Barrett R., Zhang X., Yeager N., Koon H.W., Phaosawasdi P., et al. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis. PLoS ONE 2011, 6:e16090.
25. Xiao Q., Hsu C.Y., Chen H., Ma X., Xu J., Lee J.M. Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter. Biochem J 2005, 388:913-920.
26. Safaya S., Klings E.S., Odhiambo A., Li G., Farber H.W., Steinberg M.H. Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: differential expression patterns in pulmonary artery and microvascular endothelial cells. Cytokine 2009, 46:72-78.
27. Endo K., Kinouchi Y., Kakuta Y., Ueki N., Takahashi S., Shimosegawa T. Involvement of NF-kappa B pathway in TL1A gene expression induced by lipopolysaccharide. Cytokine 2010, 49:215-220.
28. Barr R.K., Kendrick T.S., Bogoyevitch M.A. Identification of the critical features of a small peptide inhibitor of JNK activity. J Biol Chem 2002, 277:10987-10997.
29. Lin Y.Z., Yao S.Y., Veach R.A., Torgerson T.R., Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995, 270:14255-14258.
30. Yamazaki K., McGovern D., Ragoussis J., Paolucci M., Butler H., Jewell D., et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005, 14:3499-3506.
31. Wang K., Baldassano R., Zhang H., Qu H.Q., Imielinski M., Kugathasan S., et al. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet 2010, 19:2059-2067.
32. Kakuta Y., Ueki N., Kinouchi Y., Negoro K., Endo K., Nomura E., et al. TNFSF15 transcripts from risk haplotype for Crohn's disease are overexpressed in stimulated T cells. Hum Mol Genet 2009, 18:1089-1098.